Browsing by Subject "Rectal neoplasms"

Now showing items 1-4 of 4

    • Ablação de tumor de canal anal tratado com laser de diodo: seguimento após 17 meses 

      Plapler, Helio [UNIFESP] (Colégio Brasileiro de Cirurgiões, 2004-08-01)
      The Nd:YAG laser is used as the palliative treatment of obstructive and/or hemorrhagic intestinal lesions with an effective but temporary symptomatic relief, with symptoms and signs recurrence after six to eight weeks. ...

    • Colonoscopia ou sigmoidoscopia: risco de lesões isoladas no cólon direito 

      Nakao, Frank Shigueo [UNIFESP]; Cury, Marcelo De Souza [UNIFESP]; Ferrari, Angelo Paulo [UNIFESP] (Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED, 2001-09-01)
      Background Colorectal cancer is an important cause of death in western countries. Screening methods are based on flexible sigmoidoscopy, a cheap, effective, and less painful procedure, but some important lesions on the ...

    • Marcadores tumorais no câncer colorretal 

      Fernandes, Luís César [UNIFESP]; Matos, Delcio [UNIFESP] (Colégio Brasileiro de Cirurgiões, 2002-04-01)
      Colorectal cancer is a clinical entity of a persistent relevance in clinical practice and its early diagnosis is a determinant factor to obtain better therapeutic results. Tumor markers are helpful means for a better ...

    • Peripheral and mesenteric serum levels of CEA and cytokeratins, staging and histopathological variables in colorectal adenocarcinoma 

      Ivankovics, Ivan Gregorio [UNIFESP]; Fernandes, Luis Cesar [UNIFESP]; Saad, Sarhan Sydeney [UNIFESP]; Matos, Delcio [UNIFESP] (W J G Press, 2008-11-21)
      AIM: To evaluate the differences that exist between peripheral and mesenteric serum levels of carcinoembryonic antigen (CEA) and cytokeratins in patients with colorectal adenocarcinoma.METHODS: One hundred and thirty-eight ...